Examining Oversight Reports on the 340B Drug Pricing Program
Senate Committee on Health, Education, Labor, and Pensions Testimony on Examining Oversight Reports on the 340B Drug Pricing Program
May 15, 2015, 1:15 p.m.Ann Maxwell, Deputy Inspector General for Evaluation and Inspections, Office of Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services
